Slone Epidemiology Center at Boston University, Boston, MA, USA.
Pinney Associates, Pittsburgh, PA, USA.
Br J Clin Pharmacol. 2019 May;85(5):1028-1034. doi: 10.1111/bcp.13894. Epub 2019 Mar 18.
Temporal patterns of acetaminophen use exceeding the recommended daily maximum dosage of 4 g over a 5-year period (4/1/2011-3/31/2016) were evaluated in an online 1-week diary study of 14 434 adult acetaminophen users who also reported acetaminophen use in the previous month. Specific medications taken were identified by list-based prompting; respondents were not required to know their medications contained acetaminophen. Details of use were recorded daily; total daily dosage was determined programmatically. Prevalence of >4 g use over time was modelled and tested for linear changes. The overall prevalence of >4 g use (6.3% of users and 3.7% of usage days) did not change over the 5 years: odds ratio (OR) persons, 1.02 (95% CI, 0.98-1.09); OR days, 0.98 (0.92-1.05). Deviations from label directions were largely unchanged, though concomitant use increased slightly. Thus, over a recent 5-year period, there was no evidence of change in how often acetaminophen use exceeded the labelled maximum daily dose.
在一项为期一周的在线日记研究中,评估了 14,434 名成年对乙酰氨基酚使用者在过去 5 年内(2011 年 4 月 1 日至 2016 年 3 月 31 日)超过推荐的每日最大剂量 4 g 的使用时间模式,这些患者还报告了过去一个月内使用过对乙酰氨基酚。通过基于列表的提示确定特定药物的使用情况;不需要受访者知道他们的药物含有对乙酰氨基酚。使用情况每天都有记录;总日剂量通过程序确定。对随时间推移>4 g 使用的流行率进行建模,并对线性变化进行检验。5 年内>4 g 使用的总体流行率(6.3%的使用者和 3.7%的使用日)没有变化:人员的比值比(OR),1.02(95%置信区间,0.98-1.09);天数的比值比,0.98(0.92-1.05)。尽管同时使用的情况略有增加,但偏离标签说明的情况基本保持不变。因此,在最近的 5 年期间,没有证据表明对乙酰氨基酚使用超过标签最大日剂量的频率发生变化。